Paladin Partners LLC Takes $566,000 Position in Intuitive Surgical, Inc. $ISRG

Paladin Partners LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,422 shares of the medical equipment provider’s stock, valued at approximately $566,000. Intuitive Surgical accounts for approximately 0.4% of Paladin Partners LLC’s holdings, making the stock its 28th biggest holding.

A number of other large investors also recently bought and sold shares of ISRG. Main Street Group LTD bought a new position in shares of Intuitive Surgical in the 1st quarter worth $30,000. Laurel Wealth Advisors LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at about $31,000. Vermillion Wealth Management Inc. grew its stake in Intuitive Surgical by 58.1% in the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after purchasing an additional 25 shares during the last quarter. Turning Point Benefit Group Inc. grew its stake in Intuitive Surgical by 833.3% in the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 50 shares during the last quarter. Finally, Motiv8 Investments LLC bought a new position in Intuitive Surgical in the fourth quarter worth about $34,000. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on ISRG shares. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday. The Goldman Sachs Group set a $558.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, May 27th. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday. Wells Fargo & Company reissued an “overweight” rating and set a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. Finally, Evercore set a $430.00 target price on shares of Intuitive Surgical in a research note on Monday, July 6th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $508.68.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Gary S. Guthart sold 10,000 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the sale, the director owned 1,245,679 shares in the company, valued at approximately $498,271,600. The trade was a 0.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 72 shares of the stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total value of $28,303.20. Following the completion of the transaction, the director directly owned 179 shares in the company, valued at $70,364.90. This represents a 28.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 17,088 shares of company stock valued at $6,941,913 over the last three months. 0.60% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Down 1.1%

Shares of Intuitive Surgical stock opened at $390.33 on Tuesday. The company has a 50 day moving average price of $390.88 and a 200 day moving average price of $439.71. The firm has a market capitalization of $137.90 billion, a P/E ratio of 44.71, a PEG ratio of 2.85 and a beta of 1.47. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. The company had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. Intuitive Surgical’s revenue was up 18.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.81 EPS. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.